chr4:89011302:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr4:89,011,302-89,152,780 |
hg38 | chr4:88,090,150-88,231,628 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.006 | squamous cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Cardiovascular Diseases | NA | GAD | Detail | |
0.002 | brain ischemia | NA | GAD | Detail | |
<0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
<0.001 | cholelithiasis | NA | BeFree | Detail | |
<0.001 | cholestasis | NA | BeFree | Detail | |
0.004 | choriocarcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
0.003 | Colonic Neoplasms | NA | LHGDN | Detail | |
0.002 | colorectal carcinoma | Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresist... | BeFree | 26386386 | Detail |
0.127 | Colorectal Neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
<0.001 | Coronary Arteriosclerosis | Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci ... | BeFree | 25634581 | Detail |
0.003 | Coronary heart disease | Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci ... | BeFree,GAD | 25634581 | Detail |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
0.002 | Deafness | NA | GAD | Detail | |
<0.001 | Delirium | NA | BeFree | Detail | |
<0.001 | Demyelinating Diseases | NA | BeFree | Detail | |
0.120 | dental caries | NA | GWASCAT | Detail | |
0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
<0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
0.006 | diarrhea | NA | BeFree,GAD | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | Bacterial Endocarditis | NA | BeFree | Detail | |
<0.001 | Ependymoma | NA | BeFree | Detail | |
0.001 | epilepsy | NA | BeFree | Detail | |
0.002 | Exanthema | NA | GAD | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
<0.001 | Folic Acid Deficiency | NA | BeFree | Detail | |
0.002 | glioblastoma | The mRNA levels of stemness genes such as Nanog, CD133, and ABCG2 were much high... | BeFree | 25359730 | Detail |
0.002 | glioblastoma | Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through exp... | BeFree | 25644290 | Detail |
0.004 | Glioma | NA | BeFree,GAD | Detail | |
0.142 | gout | NA | BeFree,GAD,GWASCAT | Detail | |
0.005 | Head and Neck Neoplasms | NA | GAD | Detail | |
0.002 | Hearing Loss, Partial | NA | GAD | Detail | |
<0.001 | Heart failure | NA | BeFree | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
0.001 | HIV Infections | NA | BeFree | Detail | |
<0.001 | Hypercholesterolemia, Familial | Statin treatment decreased ABCG2 expression and function in patients with FH. | BeFree | 25084202 | Detail |
<0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
<0.001 | ischemia | NA | BeFree | Detail | |
<0.001 | Transient ischemia | NA | BeFree | Detail | |
<0.001 | Jaundice, Chronic Idiopathic | NA | BeFree | Detail | |
0.002 | leukemia | Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels ... | BeFree | 24954033 | Detail |
0.002 | leukemia | Patients with ABCG2 overexpression at AML diagnosis have lower leukemia free sur... | BeFree | 26059733 | Detail |
0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
0.002 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
0.028 | Leukemia, Myelocytic, Acute | A median fluorescence intensity ratio (MFIR) which measures the efflux of mitoxa... | BeFree,GAD,LHGDN | 26002514 | Detail |
0.028 | Leukemia, Myelocytic, Acute | ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cel... | BeFree,GAD,LHGDN | 26059733 | Detail |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
0.011 | Myeloid Leukemia, Chronic | The aim of the study was to investigate any possible influence of polymorphisms ... | BeFree,GAD | 24589908 | Detail |
0.002 | Leukemia, Myeloid, Chronic-Phase | NA | GAD | Detail | |
<0.001 | leukopenia | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree | 25340731 | Detail |
<0.001 | liver cirrhosis | NA | BeFree | Detail | |
<0.001 | Liver Cirrhosis, Alcoholic | NA | BeFree | Detail | |
0.120 | Biliary cirrhosis | NA | CTD_human | Detail | |
<0.001 | Liver neoplasms | NA | BeFree | Detail | |
0.013 | Lung Neoplasms | NA | GAD,LHGDN | Detail | |
0.003 | lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | macular degeneration | NA | BeFree | Detail | |
<0.001 | malaria | A female gametocyte-specific ABC transporter plays a role in lipid metabolism in... | BeFree | 25198203 | Detail |
0.002 | Malignant neoplasm of stomach | Our in vitro and in vivo experiments demonstrated that CD133(+) ABCG2(+) cells ... | BeFree | 25727099 | Detail |
0.002 | Malignant neoplasm of stomach | SHH-GLI and its downstream effector ABCG2 could be better targeted to possibly i... | BeFree | 26276718 | Detail |
<0.001 | melioidosis | NA | BeFree | Detail | |
0.001 | Mental Retardation | NA | BeFree | Detail | |
0.003 | Mesothelioma | NA | BeFree,GAD | Detail | |
<0.001 | Mild Mental Retardation | NA | BeFree | Detail | |
0.004 | multiple myeloma | NA | BeFree,LHGDN | Detail | |
0.003 | multiple sclerosis | NA | BeFree,GAD | Detail | |
0.002 | myocardial infarction | NA | GAD | Detail | |
<0.001 | Nausea | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree | 25340731 | Detail |
0.002 | Neoplasm Metastasis | Resistant cells expressed higher levels of genes coding for cancer stem cell mar... | BeFree | 25725450 | Detail |
0.002 | Neoplasm Metastasis | We propose a novel role for nuclear ABCG2 that functions as a transcription regu... | BeFree | 25810011 | Detail |
0.002 | Neoplasm Metastasis | Well-characterized clones of metastatic site-derived aggressive cells (MSDACs) f... | BeFree | 25888913 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.002 | Pathologic Neovascularization | NA | GAD | Detail | |
0.120 | nervous system disorder | NA | CTD_human | Detail | |
<0.001 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | neuromyelitis optica | NA | BeFree | Detail | |
0.008 | neutropenia | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree,GAD | 25340731 | Detail |
0.003 | obesity | ABCG2 dysfunction was observed in 53.3% of the population investigated, and its ... | BeFree,GAD | 24909660 | Detail |
<0.001 | osteosarcoma | It was concluded that the elevated expression of SATB1 in U2OS cells contributes... | BeFree | 25317073 | Detail |
0.003 | ovarian carcinoma | Under the condition of serum-free medium culture, the expression levels of CDl33... | BeFree | 25491627 | Detail |
0.003 | ovarian carcinoma | We confirmed that knockdown of BAF57 decreased BCRP expression in ovarian cancer... | BeFree | 25611552 | Detail |
0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
<0.001 | Pituitary Diseases | NA | BeFree | Detail | |
0.002 | Pleural Neoplasms | NA | GAD | Detail | |
0.006 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.002 | pseudoxanthoma elasticum | Mutations in the ABC transporter ABCC6 were recently identified as cause of Pseu... | BeFree | 25265166 | Detail |
0.003 | psoriasis | NA | BeFree,GAD | Detail | |
0.080 | Reperfusion Injury | NA | RGD | Detail | |
<0.001 | retinal degeneration | NA | BeFree | Detail | |
<0.001 | Retinal Diseases | NA | BeFree | Detail | |
<0.001 | retinitis pigmentosa | NA | BeFree | Detail | |
<0.001 | retinoblastoma | NA | BeFree | Detail | |
<0.001 | Dermatologic disorders | NA | BeFree | Detail | |
0.080 | status epilepticus | NA | RGD | Detail | |
0.003 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
<0.001 | Tangier disease | NA | BeFree | Detail | |
0.003 | Thyroid Neoplasm | NA | BeFree,LHGDN | Detail | |
0.120 | Adverse reaction to drug | NA | CTD_human | Detail | |
0.002 | Genitourinary Neoplasms | NA | GAD | Detail | |
<0.001 | Vascular Diseases | NA | BeFree | Detail | |
<0.001 | viral hepatitis | NA | BeFree | Detail | |
<0.001 | Virus Diseases | NA | BeFree | Detail | |
0.001 | intestinal volvulus | NA | BeFree | Detail | |
0.006 | B-Cell Lymphomas | NA | BeFree,LHGDN | Detail | |
0.123 | diffuse large B-cell lymphoma | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | cerebral amyloid angiopathy | NA | BeFree | Detail | |
<0.001 | Encephalopathies | NA | BeFree | Detail | |
0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Sensory neuropathy | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree | 25340731 | Detail |
0.001 | Adenocarcinoma of lung (disorder) | Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulat... | BeFree | 25603057 | Detail |
<0.001 | Malignant neoplasm of tongue | NA | BeFree | Detail | |
<0.001 | Malignant tumor of peritoneum | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of brain | NA | BeFree | Detail | |
0.002 | adrenoleukodystrophy | The human genetic disorder X-linked adrenoleukodystrophy (X-ALD) is caused by mu... | BeFree | 25118695 | Detail |
0.002 | adrenoleukodystrophy | X-linked Adrenoleukodystrophy (X-ALD), an inherited peroxisomal metabolic neurod... | BeFree | 25393703 | Detail |
<0.001 | Colitis, Ischemic | NA | BeFree | Detail | |
0.080 | erythropoietic protoporphyria | NA | BeFree,MGD | Detail | |
<0.001 | HELLP syndrome | Total bile acids in the maternal and fetal compartment in relation to placental ... | BeFree | 25446997 | Detail |
<0.001 | Dermatitis, Phototoxic | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Lichen Planus, Oral | NA | BeFree | Detail | |
0.003 | Carcinoma, Neuroendocrine | NA | BeFree,LHGDN | Detail | |
0.002 | Squamous Cell Neoplasms | NA | GAD | Detail | |
0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
<0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | Hereditary sideroblastic anemia | NA | BeFree | Detail | |
0.002 | Neurotoxicity Syndromes | NA | GAD | Detail | |
<0.001 | Retinal damage | NA | BeFree | Detail | |
<0.001 | Zinc deficiency | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
0.005 | Gastrointestinal Stromal Tumors | Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients... | BeFree,GAD,LHGDN | 25417047 | Detail |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Harlequin Fetus | NA | BeFree | Detail | |
0.012 | Malignant neoplasm of lung | We further found that the PI3K/Akt inhibitor LY294002 down-regulated BCRP expres... | BeFree,GAD | 25479544 | Detail |
0.012 | Malignant neoplasm of lung | ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cell... | BeFree,GAD | 25810011 | Detail |
<0.001 | age related macular degeneration | NA | BeFree | Detail | |
0.009 | Neoplasm, Residual | NA | BeFree,LHGDN | Detail | |
<0.001 | Chronic tophaceous gout | NA | BeFree | Detail | |
<0.001 | Progressive intrahepatic cholestasis (disorder) | NA | BeFree | Detail | |
<0.001 | Cholestasis of pregnancy | Up-regulation of placental ABCG2 may play an important role in protecting the fo... | BeFree | 25099365 | Detail |
<0.001 | Myoclonic Epilepsy, Juvenile | NA | BeFree | Detail | |
<0.001 | Tuberculosis of intestines | NA | BeFree | Detail | |
<0.001 | Infectious colitis | NA | BeFree | Detail | |
<0.001 | Prostate cancer recurrent | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | childhood acute megakaryocytic leukemia (M7) | NA | BeFree | Detail | |
<0.001 | gallbladder adenocarcinoma | NA | BeFree | Detail | |
0.003 | Solid tumour | NA | BeFree,GAD | Detail | |
<0.001 | stage, ovarian epithelial cancer | NA | BeFree | Detail | |
<0.001 | Peroxisomal Disorders | NA | BeFree | Detail | |
<0.001 | Senile Plaques | NA | BeFree | Detail | |
0.003 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree,LHGDN | Detail | |
<0.001 | Autosomal recessive retinitis pigmentosa | NA | BeFree | Detail | |
<0.001 | MRSA - Methicillin resistant Staphylococcus aureus infection | NA | BeFree | Detail | |
<0.001 | Multiple malignancy | This novel CRE site plays a central role in mediating BCRP gene expression in se... | BeFree | 25615818 | Detail |
0.002 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
<0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
<0.001 | Nevus elasticus | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | hiv-infection/aids | NA | BeFree | Detail | |
<0.001 | Overweight | ABCG2 dysfunction was observed in 53.3% of the population investigated, and its ... | BeFree | 24909660 | Detail |
<0.001 | Recurrent tumor | Our findings suggest that the overexpression of ABCG2 and the expression of stem... | BeFree | 25427584 | Detail |
<0.001 | Recurrent tumor | Therefore, the increased expression of stem cell markers and ABCG2 protein may i... | BeFree | 25633829 | Detail |
<0.001 | Metabolic syndrome X | We studied the associations between the serum uric acid concentration and the fo... | BeFree | 24827988 | Detail |
<0.001 | tongue carcinoma | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | It was concluded that the elevated expression of SATB1 in U2OS cells contributes... | BeFree | 25317073 | Detail |
<0.001 | Carcinogenesis | In conclusion, this study found that ABCC2 and ABCG2 expression levels were alte... | BeFree | 25793771 | Detail |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.002 | Epithelial ovarian cancer | NA | BeFree | Detail | |
0.017 | breast carcinoma | Inhibition or upregulation of HIF-1α affects breast cancer cell expression of BC... | BeFree | 24472707 | Detail |
0.005 | Carcinoma of lung | We further found that the PI3K/Akt inhibitor LY294002 down-regulated BCRP expres... | BeFree | 25479544 | Detail |
0.005 | Carcinoma of lung | ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cell... | BeFree | 25810011 | Detail |
<0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
<0.001 | heavy drinking | ABCG2 dysfunction was observed in 53.3% of the population investigated, and its ... | BeFree | 24909660 | Detail |
0.002 | colon carcinoma | The role of the NRF2-BCRP pathway in Pba-PDT response was further confirmed in c... | BeFree | 25226504 | Detail |
0.002 | colon carcinoma | ABCG2-meditated multidrug resistance and tumor-initiating capacity of side popul... | BeFree | 25427584 | Detail |
0.003 | stomach carcinoma | Our in vitro and in vivo experiments demonstrated that CD133(+) ABCG2(+) cells ... | BeFree | 25727099 | Detail |
0.003 | stomach carcinoma | SHH-GLI and its downstream effector ABCG2 could be better targeted to possibly i... | BeFree | 26276718 | Detail |
<0.001 | Central neuroblastoma | NA | BeFree | Detail | |
0.002 | Serum uric acid observed | NA | GAD | Detail | |
0.014 | hyperuricemia | ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion an... | BeFree,GAD | 24441388 | Detail |
0.014 | hyperuricemia | This study aimed to test the hypothesis that the ABCG2 gout risk allele 141 K pr... | BeFree,GAD | 24476385 | Detail |
0.014 | hyperuricemia | Because ABCG2 dysfunctional diplotypes were commonly observed in both Caucasians... | BeFree,GAD | 24869748 | Detail |
0.014 | hyperuricemia | Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia pro... | BeFree,GAD | 24909660 | Detail |
0.014 | hyperuricemia | Two important pathways determining hyperuricemia have been confirmed (renal and ... | BeFree,GAD | 25889045 | Detail |
0.005 | Malignant neoplasm of kidney | NA | GAD | Detail | |
<0.001 | gout tophaceous | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | Myelosuppression | NA | BeFree | Detail | |
<0.001 | Retinal Dystrophies | NA | BeFree | Detail | |
<0.001 | placental choriocarcinoma | NA | BeFree | Detail | |
<0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
0.002 | Drug-Induced Liver Injury | NA | GAD | Detail | |
<0.001 | Cardiomyopathies | NA | BeFree | Detail | |
0.006 | ovarian neoplasm | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Genomic Instability | NA | GAD | Detail | |
<0.001 | Ischemic stroke | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | We assessed 44 gene polymorphisms in 16 genes (TYMS, MTHFR, GSTP1, GSTM1, GSTT1,... | BeFree | 25677447 | Detail |
0.080 | Arthritis, Experimental | NA | RGD | Detail | |
<0.001 | Gastrooesophageal cancer | We assessed 44 gene polymorphisms in 16 genes (TYMS, MTHFR, GSTP1, GSTM1, GSTT1,... | BeFree | 25677447 | Detail |
0.002 | Mental Retardation, X-Linked | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of ovary | Under the condition of serum-free medium culture, the expression levels of CDl33... | BeFree,GAD | 25491627 | Detail |
0.004 | Malignant neoplasm of ovary | We confirmed that knockdown of BAF57 decreased BCRP expression in ovarian cancer... | BeFree,GAD | 25611552 | Detail |
0.017 | Malignant neoplasm of breast | Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 p... | BeFree | 17180579 | Detail |
0.017 | breast carcinoma | Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 p... | BeFree | 17180579 | Detail |
<0.001 | Skin toxicity | NA | BeFree | Detail | |
0.120 | Squamous cell carcinoma of the head and neck | NA | BeFree,CTD_human | Detail | |
<0.001 | dysembryoplastic neuroepithelial tumor | NA | BeFree | Detail | |
<0.001 | Primary Effusion Lymphoma | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | High ABCC2 and low ABCG2 gene expression are early events in the colorectal aden... | BeFree | 25793771 | Detail |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | ABCG2 expression was low in all renal carcinoma cell lines, and was suppressed o... | BeFree | 25455500 | Detail |
0.002 | hearing impairment | NA | GAD | Detail | |
<0.001 | Severe diarrhea | NA | BeFree | Detail | |
0.140 | Mammary Neoplasms | In particular, we analysed the association of NAC response and pre- and post-NAC... | BeFree,CTD_human,LHGDN | 24736530 | Detail |
<0.001 | Hippocampal sclerosis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.009 | colorectal cancer | Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresist... | BeFree,GAD | 26386386 | Detail |
<0.001 | Phototoxicity | NA | BeFree | Detail | |
<0.001 | infective endocarditis | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Diseases | Intestinal urate secretion may be increased at CKD state partially by upregulati... | BeFree | 25515305 | Detail |
<0.001 | Glioblastoma multiforme | The mRNA levels of stemness genes such as Nanog, CD133, and ABCG2 were much high... | BeFree | 25359730 | Detail |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | androgen independent prostate cancer | NA | BeFree | Detail | |
<0.001 | tumor vasculature | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA | NA | BeFree | Detail | |
<0.001 | Creatine deficiency, X-linked | NA | BeFree | Detail | |
<0.001 | PHOTOPAROXYSMAL RESPONSE 1 | NA | BeFree | Detail | |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
0.120 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree,CTD_human | Detail | |
0.009 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Diarrhea due to drug | NA | BeFree | Detail | |
0.006 | liver carcinoma | Yet median expression of OCT1, OCT3, and MDR1 in HCC was significantly lower (1.... | BeFree,LHGDN | 25231932 | Detail |
0.006 | liver carcinoma | We evaluated the effect of GNT on the expression and activity of P-gp, MRP2, MRP... | BeFree,LHGDN | 25781341 | Detail |
<0.001 | Mental Retardation, X-Linked 1 | NA | BeFree | Detail | |
<0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Plaque, Amyloid | NA | BeFree | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | Upon exposure of TNBC to MSC-secreted conditioned medium (CM), noticeable drug r... | BeFree | 25140317 | Detail |
<0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
0.002 | Hearing Loss | NA | GAD | Detail | |
0.005 | adenocarcinoma | NA | GAD,LHGDN | Detail | |
0.120 | adenoma | Furthermore, ABCG2 mRNA levels were significantly lower in adenomas and carcinom... | BeFree,CTD_human | 25793771 | Detail |
0.005 | Alzheimer's disease | NA | GAD | Detail | |
<0.001 | Anaplasia | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | NA | BeFree | Detail | |
0.120 | rheumatoid arthritis | NA | CTD_human | Detail | |
<0.001 | atherosclerosis | NA | BeFree | Detail | |
0.003 | Brain Neoplasms | Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain ... | BeFree,GAD | 25640271 | Detail |
0.017 | Malignant neoplasm of breast | Inhibition or upregulation of HIF-1α affects breast cancer cell expression of BC... | BeFree | 24472707 | Detail |
0.002 | Malignant tumor of colon | ABCG2-meditated multidrug resistance and tumor-initiating capacity of side popul... | BeFree | 25427584 | Detail |
0.001 | renal cell carcinoma | ABCG2 expression was low in all renal carcinoma cell lines, and was suppressed o... | BeFree | 25455500 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart ... | DisGeNET | Detail |
Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The mRNA levels of stemness genes such as Nanog, CD133, and ABCG2 were much higher in the SP cells, ... | DisGeNET | Detail |
Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP bindi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Statin treatment decreased ABCG2 expression and function in patients with FH. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 i... | DisGeNET | Detail |
Patients with ABCG2 overexpression at AML diagnosis have lower leukemia free survival (LFS) and incr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A median fluorescence intensity ratio (MFIR) which measures the efflux of mitoxantrone (an ATP Bindi... | DisGeNET | Detail |
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation ou... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of the study was to investigate any possible influence of polymorphisms of transmembrane tra... | DisGeNET | Detail |
NA | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A female gametocyte-specific ABC transporter plays a role in lipid metabolism in the malaria parasit... | DisGeNET | Detail |
Our in vitro and in vivo experiments demonstrated that CD133(+) ABCG2(+) cells exhibited well-known... | DisGeNET | Detail |
SHH-GLI and its downstream effector ABCG2 could be better targeted to possibly improve the efficacy ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
Resistant cells expressed higher levels of genes coding for cancer stem cell markers (JARID1B, CD271... | DisGeNET | Detail |
We propose a novel role for nuclear ABCG2 that functions as a transcription regulator and participat... | DisGeNET | Detail |
Well-characterized clones of metastatic site-derived aggressive cells (MSDACs) from a manifold of me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
ABCG2 dysfunction was observed in 53.3% of the population investigated, and its population-attributa... | DisGeNET | Detail |
It was concluded that the elevated expression of SATB1 in U2OS cells contributes to maintenance of t... | DisGeNET | Detail |
Under the condition of serum-free medium culture, the expression levels of CDl33+, CD117+, ABCG2, Na... | DisGeNET | Detail |
We confirmed that knockdown of BAF57 decreased BCRP expression in ovarian cancer cells by Western bl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutations in the ABC transporter ABCC6 were recently identified as cause of Pseudoxanthoma elasticum... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung ad... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The human genetic disorder X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1... | DisGeNET | Detail |
X-linked Adrenoleukodystrophy (X-ALD), an inherited peroxisomal metabolic neurodegenerative disorder... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Total bile acids in the maternal and fetal compartment in relation to placental ABCG2 expression in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We further found that the PI3K/Akt inhibitor LY294002 down-regulated BCRP expression, hence showing ... | DisGeNET | Detail |
ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Up-regulation of placental ABCG2 may play an important role in protecting the foetus from high conce... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This novel CRE site plays a central role in mediating BCRP gene expression in several human cancer c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCG2 dysfunction was observed in 53.3% of the population investigated, and its population-attributa... | DisGeNET | Detail |
Our findings suggest that the overexpression of ABCG2 and the expression of stem cell surface marker... | DisGeNET | Detail |
Therefore, the increased expression of stem cell markers and ABCG2 protein may interact with each ot... | DisGeNET | Detail |
We studied the associations between the serum uric acid concentration and the following: (i) demogra... | DisGeNET | Detail |
NA | DisGeNET | Detail |
It was concluded that the elevated expression of SATB1 in U2OS cells contributes to maintenance of t... | DisGeNET | Detail |
In conclusion, this study found that ABCC2 and ABCG2 expression levels were altered already in mild/... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inhibition or upregulation of HIF-1α affects breast cancer cell expression of BCRP; AI responsivenes... | DisGeNET | Detail |
We further found that the PI3K/Akt inhibitor LY294002 down-regulated BCRP expression, hence showing ... | DisGeNET | Detail |
ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCG2 dysfunction was observed in 53.3% of the population investigated, and its population-attributa... | DisGeNET | Detail |
The role of the NRF2-BCRP pathway in Pba-PDT response was further confirmed in colon carcinoma HT29 ... | DisGeNET | Detail |
ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from col... | DisGeNET | Detail |
Our in vitro and in vivo experiments demonstrated that CD133(+) ABCG2(+) cells exhibited well-known... | DisGeNET | Detail |
SHH-GLI and its downstream effector ABCG2 could be better targeted to possibly improve the efficacy ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overlo... | DisGeNET | Detail |
This study aimed to test the hypothesis that the ABCG2 gout risk allele 141 K promotes the hyperuric... | DisGeNET | Detail |
Because ABCG2 dysfunctional diplotypes were commonly observed in both Caucasians (16.5%) and African... | DisGeNET | Detail |
Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typica... | DisGeNET | Detail |
Two important pathways determining hyperuricemia have been confirmed (renal and gut excretion of uri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We assessed 44 gene polymorphisms in 16 genes (TYMS, MTHFR, GSTP1, GSTM1, GSTT1, DPYD, XRCC1, XRCC3,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We assessed 44 gene polymorphisms in 16 genes (TYMS, MTHFR, GSTP1, GSTM1, GSTT1, DPYD, XRCC1, XRCC3,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Under the condition of serum-free medium culture, the expression levels of CDl33+, CD117+, ABCG2, Na... | DisGeNET | Detail |
We confirmed that knockdown of BAF57 decreased BCRP expression in ovarian cancer cells by Western bl... | DisGeNET | Detail |
Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 positive/null, GSTM1 ... | DisGeNET | Detail |
Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 positive/null, GSTM1 ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCG2 expression was low in all renal carcinoma cell lines, and was suppressed only by combination t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In particular, we analysed the association of NAC response and pre- and post-NAC expression of the m... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Intestinal urate secretion may be increased at CKD state partially by upregulation of intestinal BCR... | DisGeNET | Detail |
The mRNA levels of stemness genes such as Nanog, CD133, and ABCG2 were much higher in the SP cells, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Yet median expression of OCT1, OCT3, and MDR1 in HCC was significantly lower (1.4-, 2.7-, and 2-fold... | DisGeNET | Detail |
We evaluated the effect of GNT on the expression and activity of P-gp, MRP2, MRP3 and BCRP in HCC-de... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Upon exposure of TNBC to MSC-secreted conditioned medium (CM), noticeable drug resistance against do... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, ABCG2 mRNA levels were significantly lower in adenomas and carcinomas compared to the l... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor. | DisGeNET | Detail |
Inhibition or upregulation of HIF-1α affects breast cancer cell expression of BCRP; AI responsivenes... | DisGeNET | Detail |
ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from col... | DisGeNET | Detail |
ABCG2 expression was low in all renal carcinoma cell lines, and was suppressed only by combination t... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386514057 dbSNP
- Genome
- hg19
- Position
- chr4:89,011,302-89,152,780
- Variant Type
- snv
Genome browser